Acute Generalized Exanthematous Pustulosis Induced by Docetaxel and Recurrent With Letrozole: A Case Report

Clin Breast Cancer. 2018 Oct;18(5):e743-e746. doi: 10.1016/j.clbc.2018.06.009. Epub 2018 Jun 18.

Authors

Victor Sarradin¹, Florence Dalenc², Vincent Sibaud³, Emilie Tournier⁴, Henri Roché²

Affiliations

¹ Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. Electronic address: [email protected].
² Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.
³ Department of Oncodermatology, IUCT-Oncopole, Toulouse, France.
⁴ Department of Pathology, IUCT-Oncopole, Toulouse, France.

PMID: 29980428
DOI: 10.1016/j.clbc.2018.06.009

No abstract available

Keywords: AGEP; Adverse effect; Aromatase inhibitor; Cutaneous toxicity; Taxane.

Publication types

Case Reports

MeSH terms

Acute Generalized Exanthematous Pustulosis / drug therapy
Acute Generalized Exanthematous Pustulosis / etiology*
Acute Generalized Exanthematous Pustulosis / pathology
Adrenal Cortex Hormones / therapeutic use
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects*
Antineoplastic Agents / therapeutic use
Breast Neoplasms / therapy*
Combined Modality Therapy
Docetaxel / administration & dosage
Docetaxel / adverse effects*
Docetaxel / therapeutic use
Female
Humans
Letrozole / administration & dosage
Letrozole / adverse effects*
Letrozole / therapeutic use
Middle Aged
Tamoxifen / therapeutic use
Treatment Outcome

Substances

Adrenal Cortex Hormones
Antineoplastic Agents
Tamoxifen
Docetaxel
Letrozole